1. Add-on Clarithromycin and Tacrolimus Treatment for Rheumatoid Arthritis. |
Page:123—124 |
2. Aseptic Meningitis and Acute Kidney Injury after Immunoglobulin Infusion in a Patient with Systemic Lupus Erythematosus and Immune Thrombocytopenic Purpura. |
Page:119—122 |
3. Pulmonary Arterial Hypertension is Normalized Following Six Years of Inhaled Iloprost Treatment in a Patient with Systemic Sclerosis. |
Page:114—118 |
4. Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome. |
Page:108—113 |
5. Meta-analysis of Circulating Adiponectin, Visfatin, and Ghrelin Levels in Patients with Systemic Lupus Erythematosus. |
Page:99—107 |
6. Does Painful Heels in Ankylosing Spondylitis Demonstrate Distinctive Features on Plain Radiographs: A Study of 104 Cases. |
Page:93—98 |
7. Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis as a Biomarker for Lupus Nephritis: A Meta-analysis. |
Page:85—92 |
8. Multifocal Osteonecrosis in a Patient with Gout: Case Report and Review of the Literature. |
Page:246—250 |
9. A Case of Polymyositis Associated with Immunoglobulin A Nephropathy. |
Page:241—245 |
10. Cytoplasmic Anti-Neutrophil Cytoplasmic Antibody Positive Diffuse Alveolar Hemorrhage Associated with Methimazole. |
Page:236—240 |
11. Comparing Effectiveness Rituximab (Mabthera®) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study. |
Page:227—235 |
12. Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Undergoing Biologic Disease-Modifying Therapy. |
Page:220—226 |
13. Comparative Efficacy and Safety of Secukinumab and Adalimumab in Patients with Active Ankylosing Spondylitis: A Bayesian Network Meta-analysis of Randomized Controlled Trials. |
Page:211—219 |
14. Prevalence and Risk Factors Associated with Neutropenia in Hospitalized Patients with Systemic Lupus Erythematosus. |
Page:203—210 |
15. Metabolomics Approach to Explore the Effects of Rebamipide on Inflammatory Arthritis Using Ultra Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. |
Page:192—202 |
16. Augmentation Index in Connective Tissue Diseases. |
Page:185—191 |
17. Renal Involvement in Rheumatic Diseases. |
Page:174—184 |
18. Autologous Haematopoietic Stem Cell Transplantation for Refractory Rheumatic Diseases. |
Page:171—173 |
19. A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab. |
Page:157—160 |
20. Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation for Refractory Rheumatic Diseases. |
Page:149—156 |
21. Platelet Distribution Width and Mean Platelet Volume Are Not Correlated with the Disease Activity Indices of Ankylosing Spondylitis. |
Page:143—148 |
22. Neutrophil-to-lymphocyte Ratio in Diagnosis of Systemic Sclerosis for Prediction of Interstitial Lung Disease. |
Page:138—142 |
23. Differential Diagnosis of Juvenile Idiopathic Arthritis. |
Page:131—137 |
24. Hyper-homocysteinemia Inducing Hyperuricemia: What are the Mechanisms?. |
Page:127—130 |
25. Is Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis a Biomarker of Lupus Nephritis?. |
Page:125—126 |
26. Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk. |
Page:74—84 |
27. The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus. |
Page:65—73 |
28. Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies. |
Page:63—64 |
29. Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk. |
Page:74—84 |
30. The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus. |
Page:65—73 |
31. Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies. |
Page:63—64 |
32. A Case of Paget's Disease Involving Pelvic Bone in a Patient with Tophaceous Gouty Arthritis. |
Page:60—61 |
33. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnosis and Assessment of Takayasu Arteritis and Ulcerative Colitis. |
Page:55—59 |
34. Four Cases of Polyarteritis Nodosa Presenting Initially as Pain and Pitting Edema in Both Lower Extremities. |
Page:48—54 |
35. Refractory Pleural Effusion in Systemic Lupus Erythematosus Treated by Pleurectomy. |
Page:43—47 |
36. Nutrient Intake in Postmenopausal Rheumatoid Arthritis Women with Osteoporosis: Results from the Korean National Health and Nutrition Examination Survey. |
Page:35—42 |
37. Cost-effectiveness of Non-steroidal Anti-inflammatory Drugs Adjusting for Upper and Lower Gastrointestinal Toxicities in Rheumatoid Arthritis Patients. |
Page:27—34 |
38. Manifestations of Cervical Spine Involvement in Longstanding Ankylosing Spondylitis: Atlantoaxial Ankylosis and Atlantoaxial Subluxation. |
Page:21—26 |
39. Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases. |
Page:14—20 |
40. Nuclear Medicine Imaging in Rheumatic Diseases. |
Page:4—13 |
41. Homo-Genius: Homocitrulline Can Be a Better Target than Citrulline as a Biomarker for Rheumatoid Arthritis?. |
Page:1—3 |
42. Recurrent Aseptic Meningitis in Kikuchi-Fujimoto Disease: A Not So Benign Disease?. |
Page:318—320 |
43. Pancreatic Neuroendocrine Tumor Presenting with Arthritis and Panniculitis. |
Page:313—317 |
44. Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review. |
Page:309—312 |
45. Focal Eosinophilic Myositis Associated with Behçet's Disease. |
Page:303—308 |
46. Cardiovascular and Gastrointestinal Effects of Etoricoxib in the Treatment of Osteoarthritis: A Systematic Review and Network Meta-analysis. |
Page:293—302 |
47. Comparison of the Disease Activity Score-28 Based on the Erythrocyte Sedimentation Rate and C-reactive Protein in Rheumatoid Arthritis. |
Page:287—292 |
48. Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Mean Platelet Volume with Systemic Lupus Erythematosus Disease Activity: A Meta-analysis. |
Page:279—286 |
49. Interleukin-17 Enhances Germinal Center Formation and Immunoglobulin G1 Production in Mice. |
Page:271—278 |
50. Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy. |
Page:261—270 |
51. The Role of Bile Acid Receptors in Chronic Inflammatory Diseases. |
Page:253—260 |
52. Association between Treatment with Biologic Agents and the Incidence of Herpes Zoster in Rheumatoid Arthritis. |
Page:251—252 |
53. Progressive Occipitocervical Subluxation Despite Biologic Agent Therapy in a Patient with Advanced Rheumatoid Arthritis. |
Page:169—170 |
54. Hypereosinophilic Syndrome Associated with the Onset of Rheumatoid Arthritis: A Case Report. |
Page:165—168 |
55. A Case of Neutrophilic Myositis. |
Page:161—164 |